Tradestie Institutional Equity Comparison Engine

CVM vs OBIO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CVM Overall Edge

CVM Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cel-Sci Corporation (CVM) driven by superior Valuation, Growth & Margin while OBIO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CVM trades at 23.0x Forward P/E with 0.0% operating margin (-62.7% YoY revenue) versus OBIO at N/M Forward P/E and -195.4% operating margin (-89.4% YoY). In options structure, CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against OBIO sits in BREAKOUT (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
CVM 23.0x vs OBIO N/M Fwd P/E
Growth & Margin Winner CVM
Op Margin 0.0% vs -195.4% ยท YoY -62.7% vs -89.4%
Momentum & Technical Winner OBIO
1Y -73.0% vs +78.2% ยท 52W Pos 15% vs 89%
Options & Structure Winner OBIO
BREAKDOWN (N/A IV) vs BREAKOUT (<1st %ile IV)
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.91
+14.76% 1D
Market Cap $22.5M
1M Return +15.45%
1Y Return -72.98%
Forward P/E 23.0x
Unified AI Score
43.5 / 100 HOLD
Tech 23.0 Fund 47.0 Flow 50.0 Mom 54.0
OBIO NASDAQ
Orchestra BioMed Holdings, Inc. Ordinary Shares
Surgical & Medical Instruments & Apparatus
$7.02
-1.4% 1D
Market Cap $570.6M
1M Return +24.25%
1Y Return +78.17%
Forward P/E N/M
Unified AI Score
42.9 / 100 HOLD
Tech 15.0 Fund 40.0 Flow 62.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CVM -72.98% OBIO +78.17% Spread: +149.39 pp (OBIO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CVM Revenue OBIO Revenue CVM Op. Margin OBIO Op. Margin Margin Edge
FY2011 $0M N/A -1881.0% N/A CVM
FY2012 $0M N/A -6772.3% N/A CVM
FY2013 $0M N/A -12450.1% N/A CVM
FY2014 $0M N/A -9721.4% N/A CVM
FY2022 N/A $0M N/A -924.3% OBIO
FY2023 N/A $0M N/A -1866.2% OBIO
FY2024 N/A $0M N/A -2437.5% OBIO
FY2025 N/A $30M N/A -154.7% OBIO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CVM (6) vs OBIO (4)
Institutional Metric CVM OBIO Criterion Row Winner
Market Capitalization Scale $22.5M $570.6M Larger Scale OBIO
Trailing P/E Ratio Valuation 23.0x N/M Lower Multiple CVM
Forward P/E Ratio Valuation 23.0x N/M Lower Multiple CVM
Revenue Growth (YoY) Growth -62.7% -89.4% Higher Growth CVM
Operating Margin (TTM) Profitability 0.0% -195.4% Higher Margin CVM
Net Profit Margin Profitability 0.0% -182.5% Higher Margin CVM
Return on Equity (ROE) Capital Efficiency -252.5% -182.3% Higher ROE OBIO
52-Week Range Position Momentum 15% ($1โ€“$8) 89% ($3โ€“$7) Stronger Trend OBIO
Beta / 30D Volatility Risk Regime 0.45ฮฒ ยท 139% Vol 1.15ฮฒ ยท 80% Vol Lower Realized Risk OBIO
Unified Institutional Score Composite Signal 43.5 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite CVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CVM vs OBIO Buy Guide
CVM BREAKDOWN
29d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OBIO BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live OBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CVM nor OBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.